Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 9, 2026
Accession Number:
0001213900-26-040545
Submission Type:
POS AM
CIK:
0001139685
Company Name:
20/20 Biolabs, Inc.
File Number:
333-292125